Galenic formulations of organic compounds

Details for Australian Patent Application No. 2005224010 (hide)

Owner Novartis AG

Inventors Schmid, Martin; Rigassi-Dietrich, Petra Gisela

Agent Davies Collison Cave

Pub. Number AU-B-2005224010

PCT Pub. Number WO2005/089729

Priority 60/553,878 17.03.04 US

Filing date 16 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 26 February 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/00 (2006.01)

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/089729 Priority application(s): WO2005/089729

26 February 2009 Application Accepted

  Published as AU-B-2005224010

25 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224012-Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose

2005224008-Pharmaceutical formulations for dry powder inhalers comprising a lowdosage strength active ingredient